The impact of lifetime alcohol use on hepatitis C treatment outcomes in privately insured members of an integrated health care plan†
Version of Record online: 4 OCT 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 56, Issue 4, pages 1223–1230, October 2012
How to Cite
Russell, M., Pauly, M. P., Moore, C. D., Chia, C., Dorrell, J., Cunanan, R. J., Witt, G. and Martin, S. (2012), The impact of lifetime alcohol use on hepatitis C treatment outcomes in privately insured members of an integrated health care plan. Hepatology, 56: 1223–1230. doi: 10.1002/hep.25755
Potential conflict of interest: Dr. Pauly has participated in clinical trials of antiviral therapy funded by Merck and has received grants from Merck.
- Issue online: 4 OCT 2012
- Version of Record online: 4 OCT 2012
- Accepted manuscript online: 5 APR 2012 04:35AM EST
- Manuscript Accepted: 26 MAR 2012
- Manuscript Received: 20 DEC 2011
- National Institutes of Health. Grant Number: R01AA016231-03
- Lifetime Drinking Patterns & HCV Treatment Outcomes
- 2Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: The National Academies Press; 2010., .
- 11National Institute on Alcohol Abuse and Alcoholism (NIAAA). Helping Patients Who Drink Too Much: A Clinicians' Guide, Updated 2005 Edition. Washington, DC: National Institute on Alcohol Abuse and Alcoholism; 2005.